Hospital Regional de Alta Especialidad de Zumpango Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04510662
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Abraham Edgar Gracia-Ramos | Hospital Regional de Alta Especialidad de Zumpango

Active Ingredients

Drugs in Phase 2 Trials (1)

telmisartan (micardis) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 2)

Pulmonary Valve Insufficiency (Phase 2)

Respiratory Distress Syndrome (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Respiratory Insufficiency (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1